Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 3, 2026

Back to today

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3 margins and non-GLP biologics demand.

STVN $5.4B
Best Anchor Stocks 3 clicks

From X

@calvinblissett 1 click

Calvin Blissett on X

@MBoquard Thanks Michel. My take on $ANGI Q3: The quarter was better than the stock implies. • Revenue $242M, -9% YoY (improved from -11% in Q2), in line with consensus • Adj. EBITDA $42.2M vs ~$29M expected, 17.4% margin • Proprietary service requests flat at 3.8M, revenue per lead +10%, Large Pro revenue +20%+ • EPS missed ($0.03 vs $0.11), but that's non-cash accelerated depreciation from retiring the legacy platform The balance sheet isn't the problem I made it out to be: • $202.5M cash vs $398.7M of 3.875% notes due Aug 2028, not within a year • $175M revolver undrawn to 2030 • Bought back ~$100M of bonds below par YTD ($8.4M gain) • ~$196M net debt, roughly 1.5x EBITDA • At $5.99: ~$246M mkt cap, ~$440M EV, ~2.6x Q3 run-rate EBITDA, ~3.4x trailing The real problem is supply, not demand: • Avg monthly active pros 101K, -14% • Monthly pro churn 6.7% vs 5.9% a year ago • Leads -18%, network service requests -33% (partly deliberate cuts to low-quality traffic) • 9M FCF -$7M vs +$34M last year. Operating cash flow $38M vs $93M of adj. EBITDA, with $45M of capex during the platform migration • The 300-role cut ($50-60M run-rate savings) comes with $18-30M of restructuring charges through 1H27 What the AlphaSense expert calls say: • Former Angi VP (Oct 12): recent declines are "primarily due to a shrinking base of service providers, not a loss of homeowner demand or LLM-driven disruption." • Former Angi GM (Sep 22): believes the business "has already hit its lowest point" and sees "limited downside risk from current levels." Blames a poorly executed rebrand for the lost organic traffic. • Former Angi Director of Product (Sep 21): bearish. Sees conversational AI as "an existential threat" that could bypass marketplaces entirely. • Nextdoor marketing lead (Oct 14): Google AI Overviews pose "a significant threat to Angi's organic traffic," and Thumbtack is outspending Angi on brand. • Former Angi VP of Finance (Oct 12): skeptical the international margins can be replicated in the US; integration and cost work is "far from complete." How I see it: If pros stabilize, capex drops now that the migration is done, and they keep retiring notes below par, I get to roughly $60-80M of FCF in 2027 on a ~$246M market cap. That's my estimate, not guidance. If churn keeps rising and AI starts showing up in proprietary service requests, the 17% margin is just cost cuts on a shrinking business. What I'm watching: tomorrow's call (new CEO Mike Steib, ~45 days in) and the Nov 17 investor day for 2027 targets, pro count, capex and what they do with the cash. Not investment advice.
@StableBread

Fajasy on X

Fuel Tech's $FTEK new CEO used his first earnings release to make acquisitions part of the plan, with $27.8M of cash and investments against a $44M market cap. Ramesh Nuggihalli, a former COO of competitor CECO Environmental $CECO, took over the power plant pollution-control company in August. He's pursuing organic growth in core markets, data center power, and water treatment, plus "select M&A" to add products and sales channels. Its cash and investments come to $0.89/share, ~63% of the $1.42 stock price. So I read the new plan as a choice for the cash: (1) Either it stays the floor under the stock, or (2) it becomes the budget for deals. Q3 revenue rose 16% to $8.7M, and the $267K net loss was its smallest this year (vs. a $303K profit a year ago). But air pollution control (APC) gross margin fell to 40% from 47% a year ago on project mix. APC backlog reached ~$20M with October's $3.3M of awards, but none of this year's awards is a data center order. Q3 also had the year's biggest drop in cash and investments, $1.8M, but receivables rose ~$2.0M as APC projects ramped, so the drop is mostly money customers owe, not money lost. At $1.42/share, $FTEK trades ~19% above its $1.19/share book value and below the $1.72-2.17 sum-of-the-parts in my August 27 deep dive. Would you rather $FTEK spend its cash on a deal or keep it as the floor? I'd rather hear three answers on the November 4 call before giving the new plan credit: 1) M&A: How much of the $27.8M the board would spend, and whether it would pay in cash or in stock trading near book value. 2) Data center: Whether the August talks with a data center customer about paying to reserve $FTEK's capacity are still going. 3) Margins: Whether the ~$20M backlog carries the 40% APC margin from Q3 or the 47% from a year ago.

Investor Letters

All letters

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B
John Hempton's Newsletter 3 clicks

Verra veerer

Verra Mobility’s Avis termination threatens 2027 earnings, while Government Solutions profit rose 25% and implied fourth-quarter guidance…

VRRM $404M
The Oak Bloke 2 clicks
TY · long

Tri-continental CORP

Tri-Continental Corp is presented as a long investment-grade fixed-income idea for portfolios with limited liquidity and diversification.

TY $1.8B
Value Investors Club 2 clicks

Sixty Dollars or Nothing

Chiron granted seven executives 195,610 options at a $60 strike, 63% above the market price and above its published valuation range.

XRN $402M
Orphan REITs

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 73 of 273

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

286 firms

Sectors

Ordered by how often our editor reaches for them.